UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Long-term outcome of fat grafting to treat facial Systemic Sclerosis: a prospective cohort study

Almadori, Aurora; Griffin, Michelle; Hyun, Jeon; Hansen, Esther; Denton, Christopher P; Butler, Peter EM; (2025) Long-term outcome of fat grafting to treat facial Systemic Sclerosis: a prospective cohort study. Plastic and Reconstructive Surgery , 156 (4) pp. 611-621. 10.1097/PRS.0000000000012111. Green open access

[thumbnail of long_term_outcome_of_fat_grafting_to_treat_facial.31.pdf]
Preview
Text
long_term_outcome_of_fat_grafting_to_treat_facial.31.pdf

Download (1MB) | Preview

Abstract

Background: Systemic Sclerosis (SSc) is characterized by subcutaneous tissue loss and dermal fibrosis, with limited facial movement and mouth opening. Fat grafting is a minimally invasive technique used to restore facial volume and improve skin fibrosis. // Materials and methods: A cohort of 93 patients were assessed using 3D imaging (3dMD) before and after fat grafting. Secondary outcomes included physician-based assessment, mouth function (MHISS), psychological status, quality of life (DAS, HADS, VAS, BFNES), and patient-based satisfaction. // Results: After an average of 2.96 (±2.2) sessions of fat grafting, with an injection volume of 11.9 cc (±6) in each session, the overall retention rate was 53.1% (±0.17) at an average follow-up of 3.11 (±1.73) years. Patients undergoing 5+ interventions presented a higher retention rate (73.1% ±0.08%) than those receiving one or two treatments (45.2% ±0.09 and 50.5% ±0.15 respectively) (P<0.05). Significant improvements were found in mouth function (P<0.0001) and quality of life (P<0.0001). // Conclusion: Facial fat grafting is an effective technique for restoring facial volume and improving oral function and quality of life in patients with scleroderma. This study presents the largest number of patients published to date with the longest follow-up period.

Type: Article
Title: Long-term outcome of fat grafting to treat facial Systemic Sclerosis: a prospective cohort study
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1097/PRS.0000000000012111
Publisher version: https://doi.org/10.1097/prs.0000000000012111
Language: English
Additional information: Copyright © 2025 The Authors. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10206885
Downloads since deposit
41Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item